Posted on 13 December, 2012

Photo: Multidrug-Resistant TB in Tajikstan 2012 © Ron Haviv/VII
Fatal NeglectMultidrug-Resistant TB: No Promises 
Patients with tuberculosis must undergo lengthy, arduous treatment regimens in the best of times. When stricken with multidrug-resistant tuberculosis, or MDR-TB, however, the road back to health is even more difficult.
The most neglected are children living with MDR-TB. VII Photo’s Ron Haviv visited MSF’s pediatric MDR-TB program in Tajikistan, one of Asia’s poorest countries, where the disease is indeed spreading at an alarming rate. Through the experience of an MSF nurse trying to care for children suffering with the disease, Haviv documents this new and very dangerous medical front line.
REGISTER NOW to join the live webcast of our conference this week on global health, neglected diseases, and R&D.

Photo: Multidrug-Resistant TB in Tajikstan 2012 © Ron Haviv/VII

Fatal Neglect
Multidrug-Resistant TB: No Promises 

Patients with tuberculosis must undergo lengthy, arduous treatment regimens in the best of times. When stricken with multidrug-resistant tuberculosis, or MDR-TB, however, the road back to health is even more difficult.

The most neglected are children living with MDR-TB. VII Photo’s Ron Haviv visited MSF’s pediatric MDR-TB program in Tajikistan, one of Asia’s poorest countries, where the disease is indeed spreading at an alarming rate. Through the experience of an MSF nurse trying to care for children suffering with the disease, Haviv documents this new and very dangerous medical front line.

REGISTER NOW to join the live webcast of our conference this week on global health, neglected diseases, and R&D.

Fatal Neglect
Multidrug-Resistant TB: No Promises 

image

REGISTER NOW to join the live webcast of our conference this week on global health, neglected diseases, and R&D.

Thanks to your generosity, we can save more lives.

With your support, our medical teams will be able to save more lives around the world. Please support Doctors Without Borders today to help us provide humanitarian medical aid to people where the need is greatest.

DONATE NOW

The announcement by the French government to prioritize global health research and development is an important step toward making sure life-saving drugs and medical tools are developed and delivered to the people who need them most. We call on additional governments to set up similar financial transaction taxes and to follow the French government’s move to dedicate a portion of the revenue to respond to neglected health needs. Every day in our work, we witness firsthand the failures of today’s health research and development system that does not deliver adequately for people in developing countries.

Sophie Delaunay, Executive Director, MSF-USA, in response to the French government’s announcement that a portion of the financial transaction tax they have decided to implement will be dedicated to global health research and development.

The announcement was made by Fabienne Bartoli, Social Development Counselor at the French Mission to the United Nations at the MSF/Drugs for Neglected Diseases initiative conference on R&D for neglected populations in New York, December 13, 2012.